During the past decade, DRC Gyogyszervizsgalo Kozpont Kft conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 32 clinical trials were completed, i.e. on average, 74.4% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 23 clinical trials were completed. i.e. 104.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DRC Gyogyszervizsgalo Kozpont Kft" #1 sponsor was "Pfizer" with 11 trials, followed by "Eli Lilly and Company" with 7 trials sponsored, "Celgene" with 4 trials sponsored, "Abivax S.A." with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DRC Gyogyszervizsgalo Kozpont Kft" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Eurofins Optimed" with 2 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "DRC Gyogyszervizsgalo Kozpont Kft" are "Ulcerative Colitis" (10 trials), "Rheumatoid Arthritis" (8 trials), "Crohn's Disease" (4 trials), "Diabetes Mellitus, Type 2" (4 trials) and "Type 2 Diabetes Mellitus" (4 trials). Many other conditions were trialed in "DRC Gyogyszervizsgalo Kozpont Kft" in a lesser frequency.

Most popular intervention types in "DRC Gyogyszervizsgalo Kozpont Kft" are "Drug" (54 trials), "Biological" (4 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Etrasimod" (3 trials), "K-877" (3 trials), "ABX464" (2 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "DRC Gyogyszervizsgalo Kozpont Kft" are 58 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "DRC Gyogyszervizsgalo Kozpont Kft". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in DRC Gyogyszervizsgalo Kozpont Kft, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in DRC Gyogyszervizsgalo Kozpont Kft, 5 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".